Selected stock price target news of the day - October 15th, 2025
By: Matthew Otto Genmab Posts Third-Quarter Results for DARZALEX® Amid Continued Global Demand Genmab A/S reported that Johnson & Johnson recorded worldwide net sales of DARZALEX® (daratumumab) of USD 3,672 million for the third quarter of 2025. Of this total, USD 2,088 million was generated in the United States and USD 1,584 million from...
Read articleTrending topics
Selected stock price target news of the day - October 14th, 2025
By: Matthew Otto Domino’s Pizza Posts Q3 2025 Results with Moderate Sales Growth and Earnings Beat Domino’s Pizza reported third-quarter results for 2025, surpassing Wall Street expectations. The company posted earnings per share (EPS) of $4.08, exceeding analyst estimates of $3.96 by $0.12. Revenue for the quarter reached $1.15 billion, slightly ahead of the...
Read article
Selected stock price target news of the day - October 10th, 2025
By: Matthew Otto Delta Air Lines Exceeds Q3 Earnings Estimates, Forecasts Strong Finish to 2025 Delta Air Lines reported third-quarter earnings that surpassed Wall Street expectations, posting earnings per share (EPS) of $1.71, $0.18 higher than the analyst estimate of $1.53. Revenue reached $15.2 billion, above the consensus forecast of $15.04 billion, and up...
Read article